0001209191-20-038169.txt : 20200622 0001209191-20-038169.hdr.sgml : 20200622 20200622162213 ACCESSION NUMBER: 0001209191-20-038169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200610 FILED AS OF DATE: 20200622 DATE AS OF CHANGE: 20200622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bass James Edward CENTRAL INDEX KEY: 0001662321 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 20979094 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-10 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662321 Bass James Edward 5320 LEGACY DR. PLANO TX 75024 1 0 0 0 Stock Option (right to buy) 130.92 2020-06-10 4 A 0 6300 0.00 A 2030-06-10 Class A common stock 6300 6300 D Stock Option (right to buy) 130.92 2020-06-10 4 A 0 821 82.15 A 2030-06-10 Class A common stock 821 821 D The options vest in 4 equal installments on September 10, 2020, December 10, 2020, March 10, 2021, and June 10, 2021, subject to continued service through each vesting date. The options vest in the following installments: 205 shares on September 10, 2020, December 10, 2020 and March 10, 2021, respectively, and 206 shares on June 10, 2021, subject to continued service through each vesting date. This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $67,500. /s/ Tracy Herson, attorney-in-fact 2020-06-22